Fed. Circ. Affirms Illumina's $27M Patent Win Over Ariosa
The Federal Circuit on Friday affirmed Illumina Inc.'s $26.7 million win against genomics company Ariosa Diagnostics Inc., ruling that substantial evidence supported a trial judge's upholding of a jury's verdict finding...To view the full article, register now.
Already a subscriber? Click here to view full article